Biriukov V B
Zh Nevropatol Psikhiatr Im S S Korsakova. 1976 Sep;76(9):1333-5.
Patients with different forms of myotonia were treated by 2 preparations: novocainamide and Diphenine (diphenylhydantoin). Patients with Thomsen's myotonia (9 cases) and with atrophic myotonia (7 cases) were treated by novocainamide with a daily dosage of 0.75-1.5 gm during 3 weeks. A decrease of the myotonical contracture was more marked in patients with Thomsen's myotonia and was arrested following 2-3 days after its discontinuation. Treatment of patients with atrophic myotonic by novocaiamide was not feasible inasmuch as there were some contraindications for its use. In 9 cases of Thomsen's myotonia and in 5 with atrophic myotonia treatment was given by diphenine in daily dosages from 0.4-0.5 gm during 4 weeks. In 6 patients with Thomsen's myotonia and in 3 cases of atrophic myotonia there was a significant improvement. In 2 cases diphenine even in minimal doses lead to allergic reactions. No effect was marked in 3 cases. Diphenine appears to be effective in Thomsen's myotonia and in patients with atrophic myotonia with insignificant muscular atrophy. The effect after treatment lasted up to 4 weeks.
新斯的明和苯妥英(二苯乙内酰脲)。对患有托姆森氏肌强直的9例患者和萎缩性肌强直的7例患者使用新斯的明治疗,每日剂量为0.75 - 1.5克,持续3周。托姆森氏肌强直患者的肌强直挛缩减轻更为明显,停药2 - 3天后停止减轻。由于存在一些使用禁忌,用新斯的明治疗萎缩性肌强直患者不可行。对9例托姆森氏肌强直患者和5例萎缩性肌强直患者使用苯妥英治疗,每日剂量为0.4 - 0.5克,持续4周。6例托姆森氏肌强直患者和3例萎缩性肌强直患者有显著改善。2例患者即使使用最小剂量的苯妥英也出现了过敏反应。3例患者未观察到效果。苯妥英似乎对托姆森氏肌强直以及肌肉萎缩不明显的萎缩性肌强直患者有效。治疗后的效果持续长达4周。